Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.

导出 LinkOut

翻译打印收藏纠错

作者： Allison N,Schorzman ^[1] ; Andrew T,Lucas ^[1] ; John R,Kagel ^[1] ; William C,Zamboni ^[2]

作者单位： Translational Oncology and Nanoparticle Drug Development Initiative (TOND2I) Lab, UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ^[1] Translational Oncology and Nanoparticle Drug Development Initiative (TOND2I) Lab, UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Zamboni@unc.edu. ^[2]

关键词 Carrier-mediated agents Immune system Mononuclear phagocyte system (MPS)Nanoparticles Pharmacodynamics Pharmacokinetics

主题词动物(Animals);药物载体(Drug Carriers);药物释放系统(Drug Delivery Systems);人类(Humans);纳米粒子(Nanoparticles);药代动力学(Pharmacokinetics);表型(Phenotype)

DOI 10.1007/978-1-4939-8661-3_15

PMID 30051434

发布时间 2019-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交